ATH434-DP2
Phase 2 small_molecule active
Quick answer
ATH434-DP2 for Multiple System Atrophy is a Phase 2 program (small_molecule) at ALTERITY THERAPEUTICS LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALTERITY THERAPEUTICS LTD
- Indication
- Multiple System Atrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active